Pharmacological blockade or genetic deletion of substance P (NK 1 ) receptors attenuates neonatal vocalisation in guinea-pigs and mice

Pharmacological blockade or genetic deletion of substance P (NK 1 ) receptors attenuates neonatal... The regulation of stress-induced vocalisations by central NK 1 receptors was investigated using pharmacological antagonists in guinea-pigs, a species with human-like NK 1 receptors, and transgenic NK1R−/− mice. In guinea-pigs, i.c.v. infusion of the selective substance P agonist GR73632 (0.1 nmol) elicited a pronounced vocalisation response that was blocked enantioselectively by the NK 1 receptor antagonists CP-99,994 and L-733,060 (0.1–10 mg/kg). GR73632-induced vocalisations were also markedly attenuated by the antidepressant drugs imipramine and fluoxetine (30 mg/kg), but not by the benzodiazepine anxiolytic diazepam (3 mg/kg) or the 5-HT 1A agonist buspirone (10 mg/kg). Similarly, vocalisations in guinea-pig pups separated from their mothers were blocked enantioselectively by the highly brain-penetrant NK 1 receptor antagonists L-733,060 and GR205171 (ID 50 3 mg/kg), but not by the poorly brain-penetrant compounds LY303870 and CGP49823 (30 mg/kg). Separation-induced vocalisations were also blocked by the anxiolytic drugs diazepam, chlordiazepoxide and buspirone (ID 50 0.5–1 mg/kg), and by the antidepressant drugs phenelzine, imipramine, fluoxetine and venlafaxine (ID 50 3–8 mg/kg). In normal mouse pups, GR205171 attenuated neonatal vocalisations when administered at a high dose (30 mg/kg) only, consistent with its lower affinity for the rat than the guinea-pig NK 1 receptor. Ultrasound calls in NK1R−/− mouse pups were markedly reduced compared with those in WT pups, confirming the specific involvement of NK 1 receptors in the regulation of vocalisation. These observations suggest that centrally-acting NK 1 receptor antagonists may have clinical utility in the treatment of a range of anxiety and mood disorders. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Neuropharmacology Elsevier

Pharmacological blockade or genetic deletion of substance P (NK 1 ) receptors attenuates neonatal vocalisation in guinea-pigs and mice

Loading next page...
 
/lp/elsevier/pharmacological-blockade-or-genetic-deletion-of-substance-p-nk-1-5fxeQUwIQq
Publisher
Elsevier
Copyright
Copyright © 2000 Elsevier Science Ltd
ISSN
0028-3908
eISSN
1873-7064
DOI
10.1016/S0028-3908(00)00052-6
Publisher site
See Article on Publisher Site

Abstract

The regulation of stress-induced vocalisations by central NK 1 receptors was investigated using pharmacological antagonists in guinea-pigs, a species with human-like NK 1 receptors, and transgenic NK1R−/− mice. In guinea-pigs, i.c.v. infusion of the selective substance P agonist GR73632 (0.1 nmol) elicited a pronounced vocalisation response that was blocked enantioselectively by the NK 1 receptor antagonists CP-99,994 and L-733,060 (0.1–10 mg/kg). GR73632-induced vocalisations were also markedly attenuated by the antidepressant drugs imipramine and fluoxetine (30 mg/kg), but not by the benzodiazepine anxiolytic diazepam (3 mg/kg) or the 5-HT 1A agonist buspirone (10 mg/kg). Similarly, vocalisations in guinea-pig pups separated from their mothers were blocked enantioselectively by the highly brain-penetrant NK 1 receptor antagonists L-733,060 and GR205171 (ID 50 3 mg/kg), but not by the poorly brain-penetrant compounds LY303870 and CGP49823 (30 mg/kg). Separation-induced vocalisations were also blocked by the anxiolytic drugs diazepam, chlordiazepoxide and buspirone (ID 50 0.5–1 mg/kg), and by the antidepressant drugs phenelzine, imipramine, fluoxetine and venlafaxine (ID 50 3–8 mg/kg). In normal mouse pups, GR205171 attenuated neonatal vocalisations when administered at a high dose (30 mg/kg) only, consistent with its lower affinity for the rat than the guinea-pig NK 1 receptor. Ultrasound calls in NK1R−/− mouse pups were markedly reduced compared with those in WT pups, confirming the specific involvement of NK 1 receptors in the regulation of vocalisation. These observations suggest that centrally-acting NK 1 receptor antagonists may have clinical utility in the treatment of a range of anxiety and mood disorders.

Journal

NeuropharmacologyElsevier

Published: Jul 1, 2000

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off